Screening of RNA molecules inhibiting human acetylcholinesterase by virtue of systematic evolution of ligands by exponential enrichment

Acta Pharmacologica Sinica

Volumn 24, Issue 7, 2003, Pages 711-714+727

  Zhang, Xing Mei ^a   Shao, Ning Sheng ^a   Chi, Mu Gen ^a   Sun, Man Ji ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

Acetylcholinesterase; Aptamer; SELEX

Indexed keywords

ACETYLCHOLINESTERASE; APTAMER; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; LIGAND; RNA;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; EVOLUTION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROTITER PLATE ASSAY; SPECTROPHOTOMETRY;

ACETYLCHOLINESTERASE; BINDING SITES; CHOLINESTERASE INHIBITORS; COMBINATORIAL CHEMISTRY TECHNIQUES; ERYTHROCYTE MEMBRANE; HUMANS; LIGANDS; RNA; RNA-BINDING PROTEINS;

EID: 0038729584     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505-10.
2. Gold L. Oligonucleotides as research diagnostic and therapeutic agents. J Biol Chem 1995; 270: 13581-4.
3. Butz K, Denk C, Fitscher B, Cmkovic-Mertens I, Ullmann A, Schroder CH, et al. Peptide aptamers targeting the hepatitis B virus core protein: a new class of molecules with antiviral activity. Oncogene 2001; 20: 6579-86.
4. Brody EN, Gold L. Aptamers as therapeutic and diagnostic agents. J Biotechnol 2000; 74: 5-13.
5. Tarrago-Litvak L, Andreola ML, Fournier M, Nevinsky GA, Parissi V, Soultrait VR, et al. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches. Curr Pharm Des 2002; 8: 595-614.
6. Fitzwater T, Polisky B. A SELEX primer. Methods Enzymol 1996; 267: 275-301.
7. Drolet DW, Jenison RD, Smith DE, Pratt D, Hicke BJ. A high throughput platform for symstematic evolution of ligands by exponential enrichment (SELEX). Comb Chem High Throughput Screen 1999; 2: 271-8.
8. Li FZ, Sun MJ. Microcolorimetrically method of hydroxylamine to measure the acetylcholinesterase activity. Bull Acad Mil Med Sci 1986; 10: 211-4.
9. Jayasena SD. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999; 45: 1628-50.
10. Bianchini M, Radrizzani M, Brocardo MG, Reyes GB, Gonzalez Solveyra C, Santa-Coloma TA. Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein. J Immunol Methods 2001; 252: 191-7.
11. Grisaru D, Sternfeld M, Eldor A, Glick D, Soreq H. Structural roles of acetylcholinesterase variants in biology and pathology. Eur J Biochem 1999; 264: 672-86.
12. Soreq H, Glick D. Novel roles for cholinesterase in stress and inhibitor response. In: Giacobini E, editor. Cholinesterase and cholinesterase inhibitors. London: Martin Dunitz; 2000. p 47-61.